A breakthrough in trade talks with the U.S. might win Ishiba a reprieve, but so far there's been scant sign of progress in negotiating away the threat of higher tariffs on Japan's exports to the U.S.

The Trump administration ramped up its criticism of the central bank, with Treasury Secretary Scott Bessent calling for a review of the "entire Federal Reserve institution." "I think that what we need ...

The prospect of an interim trade deal between the US and India before the August 1 deadline have dimmed, according to sources ...

AstraZeneca plans to plough billions of pounds into US manufacturing as the drugs giant faces the threat of looming tariffs.

Nio faces fierce competition in China's electric vehicle market and has encountered challenges to international expansion, ...

AstraZeneca Plc plans to invest $50 billion in the US before 2030, ratcheting up spending alongside other European drugmakers ...

European shares fell on Tuesday, deflated by mixed corporate earnings, while investors took stock of tariff negotiations ...

American firm, which represents the likes of Taylor Swift and Billie Eilish, is already listed in the Netherlands. View on ...

Astrazeneca has unveiled plans to invest as much as $50bn in manufacturing and R&D in the US after ditching its UK expansion plans in a blow to the government’s industrial strategy. The ...

Coinbase’s new contracts offer 5-year durations while touting lower fees, as it aims to lure U.S. traders from offshore ...

Asian share markets drifted lower after scaling a near four-year peak on Tuesday ahead of a slate of corporate earnings, ...